Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.

200868 citationsJournal Article

Authors

David W. Dowdy · Johns Hopkins University

Abstract

Novel diagnostic tests for TB are potentially highly cost-effective. Cost-effectiveness is maximized by high-specificity, low-cost tests deployed to regions with poor infrastructure.

Topics & Keywords

Tuberculosis Research and Epidemiology Pneumonia and Respiratory Infections Immunodeficiency and Autoimmune Disorders

UN Sustainable Development Goals

Industry, innovation and infrastructure

Publication Details

Published in: PubMed

Volume 12, Issue 9, pp. 1021-9

Field-Weighted Citation Impact: 2.53